Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
1979 • 54,907 citations
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
1989 • 422 citations
B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.
1988 • 382 citations
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
1992 • 261 citations
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
1993 • 223 citations
Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.
1989 • 179 citations
Cytokines in normal and abnormal parturition: Elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection
1991 • 157 citations
Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines
1988 • 156 citations
Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.
1990 • 151 citations
High levels of “complexed” interleukin-6 in human blood.
1992 • 133 citations
Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo.
1993 • 108 citations
Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
1993 • 30 citations
Comparison of three immunoassays for C-reactive protein determination.
1985 • 9 citations